Authors
Yingying Cao, Haibo Tang, Liang Liang, Jing Leng, Weijian Huang
Published in
Animal models and experimental medicine. Aug 17, 2026. Epub Aug 17, 2026.
Abstract
The tree shrew (Tupaia belangeri) is an emerging animal model for human diseases, yet the status of the critical tumor suppressor TP53 in its subspecies and spontaneous tumors is unknown. We sequenced the entire TP53 coding region from two subspecies, T. b. yaoshanensis and T. b. chinensis, and analyzed two spontaneous sarcomas from T. b. yaoshanensis using histopathology, immunohistochemistry, and cDNA sequencing with clonal validation. TP53 showed 99.5% nucleotide identity between subspecies, with a single fixed non-synonymous substitution (D42G) in T. b. yaoshanensis predicted to be functionally neutral. All residues corresponding to human cancer hotspots were strictly conserved, and structural modeling confirmed high similarity to human p53 (RMSD = 0.6 Å). Critically, we identified TP53 sequence variants in both spontaneous tumors: a missense variant (Ser175Gly) in the DNA-binding domain of a liposarcoma and another (Met344Thr) in the tetramerization domain of a myxofibrosarcoma. Computational prediction suggested both missense variants are tolerated (SIFT scores 0.61 and 0.77), and their functional significance remains to be determined. This study provides preliminary evidence of TP53 variants in spontaneous tree shrew tumors and reveals natural subspecies variation. The high conservation of p53 reinforces the tree shrew's relevance as a model for TP53-related cancer research, although further functional studies are needed.
PMID:
42605788
Bibliographic data and abstract were imported from PubMed on 17 Aug 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 10
- Comments 0